111 related articles for article (PubMed ID: 7328664)
41. [Differentiated study of specific antibody populations as a possible way to increase the prognostic value of indicators of humoral immunity in influenza].
Meringova LF; Iakovleva IV; Voĭtsekhovskiĭ BL; Dukhin AI; Poliak RIa
Vestn Akad Med Nauk SSSR; 1989; (11):75-80. PubMed ID: 2623938
[TBL] [Abstract][Full Text] [Related]
42. Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences.
Gravel C; Li C; Wang J; Hashem AM; Jaentschke B; Xu KW; Lorbetskie B; Gingras G; Aubin Y; Van Domselaar G; Girard M; He R; Li X
Vaccine; 2010 Aug; 28(36):5774-84. PubMed ID: 20621113
[TBL] [Abstract][Full Text] [Related]
43. [Determination of standard conditions for the influenza virus neuraminidase inhibition test].
Mel'nikova SK; Gracheva EN; Alekseeva AK
Vopr Virusol; 1976; (3):283-7. PubMed ID: 988673
[No Abstract] [Full Text] [Related]
44. Catalytic properties of the A/H3N2 influenza neuraminidases: influence of antigenic variations.
Deshairs C; Kessler N; Aymard M; Quash GA
J Gen Virol; 1986 Mar; 67 ( Pt 3)():409-18. PubMed ID: 3950578
[TBL] [Abstract][Full Text] [Related]
45. Amino acid sequence changes in antigenic variants of type A influenza virus N2 neuraminidase.
Laver WG; Air GM; Webster RG; Markoff LJ
Virology; 1982 Oct; 122(2):450-60. PubMed ID: 6183823
[No Abstract] [Full Text] [Related]
46. [Characteristics of neuraminidase N1 from human influenza A viruses].
Grinbaum EB; Ivanova NA; Luzianina TIa
Tr Inst Im Pastera; 1982; 59():20-3. PubMed ID: 6196880
[No Abstract] [Full Text] [Related]
47. [Antigenic structure of the neuraminidases of vaccinal strains of influenza virus type A used in the production of live anti-influenza oral vaccine].
Mel'nikova SK; Aleksandrova AN; Alekseeva AK
Vopr Virusol; 1976; (3):287-9. PubMed ID: 62454
[No Abstract] [Full Text] [Related]
48. [Protective antigen of influenza virus].
Nobusawa E
Nihon Rinsho; 1997 Oct; 55(10):2719-24. PubMed ID: 9360397
[TBL] [Abstract][Full Text] [Related]
49. Natural infection with influenza A (H3N2). The development, persistance and effect of antibodies to the surface antigens.
Smith AJ; Davies JR
J Hyg (Lond); 1976 Oct; 77(2):271-82. PubMed ID: 185291
[TBL] [Abstract][Full Text] [Related]
50. Crystallization and preliminary diffraction studies of prostaglandin E2-specific monoclonal antibody Fab fragment in the ligand complex.
Kurahashi Y; Sugahara M; Ago H; Aoyama S; Takahashi N; Takio K; Katsukawa M; Yamamoto S; Miyano M
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Nov; 64(Pt 11):1027-30. PubMed ID: 18997333
[TBL] [Abstract][Full Text] [Related]
51. Antigenic determinants of influenza virus hemagglutinin. III. Competitive binding of antibodies directed against "common" and "strain-specific" antigenic determinants of A/Memphis/72 hemagglutinin.
Russell RJ; Burns WH; White DO; Anders EM; Ward CW; Jackson DC
J Immunol; 1979 Aug; 123(2):825-32. PubMed ID: 88484
[No Abstract] [Full Text] [Related]
52. Isolation of human monoclonal antibodies that neutralize human rotavirus.
Higo-Moriguchi K; Akahori Y; Iba Y; Kurosawa Y; Taniguchi K
J Virol; 2004 Apr; 78(7):3325-32. PubMed ID: 15016854
[TBL] [Abstract][Full Text] [Related]
53. [Determination of the neuraminidase specificity of influenza A and B viruses using a modified lectin test].
Liubovtseva OV; Zakstel'skaia LIa; Ivanova VT; Oskerko TA
Vopr Virusol; 1983; 28(6):663-8. PubMed ID: 6199899
[TBL] [Abstract][Full Text] [Related]
54. Characterization of crystals of an antibody-recognition fragment of the cancer differentiation antigen mesothelin in complex with the therapeutic antibody MORAb-009.
Ma J; Tang WK; Esser L; Pastan I; Xia D
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Aug; 68(Pt 8):950-3. PubMed ID: 22869130
[TBL] [Abstract][Full Text] [Related]
55. [Antigenic and biological characteristics of strains of the influenza A (H3N2) virus, similar to virus A/Hong Kong/68, isolated from children in the USSR in 1986].
Iakhno MA; Ivanova VT; Govorkova EA; Iamnikova SS; Isachenko VA
Vopr Virusol; 1988; 33(6):663-9. PubMed ID: 2470199
[TBL] [Abstract][Full Text] [Related]
56. [Antigenic specificity of neuraminidase and structure of neuraminidase gene of influenza A(H1N1) serotype Hsw1N1 viruses isolated from man and animals].
Chuvakova ZK; Dem'ianenko IV; Chaĭka OV; Shilov AA; Kim EV; Rovnova ZI; Isaeva EI; Isaeva ES
Vopr Virusol; 1989; 34(6):656-61. PubMed ID: 2483778
[TBL] [Abstract][Full Text] [Related]
57. [Antigenic relations between neuraminidases N 1 of human influenza viruses type A].
Grinbaum EB; Ivanova NA; Luzianina TIa; Smorodintsev AA
Virologie; 1981; 32(2):115-21. PubMed ID: 7245603
[No Abstract] [Full Text] [Related]
58. An investigation of antigenic drift of neuraminidases of influenza A (H1N1) viruses.
Luther P; Bergmann KC; Oxford JS
J Hyg (Lond); 1984 Apr; 92(2):223-9. PubMed ID: 6707471
[TBL] [Abstract][Full Text] [Related]
59. [Antigenic properties of influenza virus type A inactivated by ultraviolet irradiation].
Bokhnevich GM; Fridman EA; Peradze TV
Vopr Virusol; 1978; (1):74-9. PubMed ID: 77085
[TBL] [Abstract][Full Text] [Related]
60. The use of antibody fragments for crystallization and structure determinations.
Kovari LC; Momany C; Rossmann MG
Structure; 1995 Dec; 3(12):1291-3. PubMed ID: 8747455
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
